Renal Cancer - Results from #8940

Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): A randomised phase 2 trial - Abstract July 1, 2011

Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma? - Abstract June 30, 2011

Dose escalation and pharmacokinetics study of enzastaurin and sunitinib versus placebo and sunitinib in patients with metastatic renal cell carcinoma - Abstract June 30, 2011

Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: Recommendations from a European nursing task group - Abstract June 29, 2011

Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma - Abstract June 29, 2011

Early significant tumor volume reduction after radiosurgery in brain metastases from renal cell carcinoma results in long-term survival - Abstract June 28, 2011

Pfizer files with the FDA for review of axitinib for patients with advanced renal cell carcinoma June 28, 2011

Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma - Abstract June 27, 2011

Management of metastatic renal cell carcinoma in the era of targeted therapies - Abstract June 24, 2011

Feasibility and adequacy of robot-assisted lymphadenectomy for renal-cell carcinoma - Abstract June 24, 2011

Renal cell carcinoma of the native kidney: A frequent tumor after kidney transplantation with favorable prognosis in case of early diagnosis - Abstract June 23, 2011

Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinoma - Abstract June 23, 2011

Efficacy of sunitinib re-exposure after failure of an mTOR inhibitor in patients with metastatic RCC - Abstract June 23, 2011

The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer - Abstract June 22, 2011

Small renal mass: What the urologist needs to know for treatment planning and assessment of treatment results - Abstract June 21, 2011

Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: Final results of a prospective phase II trial - Abstract June 21, 2011

Differential genetic expression in large versus small clear cell renal cell carcinoma: Results from microarray analysis - Abstract June 21, 2011

Clear-cell papillary renal cell carcinoma: Molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins - Abstract June 20, 2011

Renal cell carcinoma: What the surgeon and treating physician need to know - Abstract June 20, 2011

Chromophobe renal cell carcinoma in Iceland: An epidemiological and clinicopathological study - Abstract June 19, 2011

Page 448 of 457